ID
41466
Description
Study ID: 105043/013 Clinical Study ID: 105043/013 Study Title: An Open-Label Study of Argatroban Injection to Evaluate the Safety and Effectiveness in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin (Protocol SKF105043/013) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00039858 - See https://clinicaltrials.gov/ct2/show/NCT00039858 Sponsor: GlaxoSmithKline Collaborators: Encysive Pharmaceuticals Phase: Phase 4 Study Recruitment Status: Completed Generic Name: Argatroban Trade Name: N/A Study Indication: Thrombosis This Study evaluates the safety and the efficacy of i.v. Argatroban treatment in paediatric patients which require anticoagulants but aren't suitable for Heparin treatment. The study consists of screening visit (pre-treatment examination), treatment period of maximum 14 days after reaching therapeutical dose, post-treatment visit (once the treatment is stopped or after 14 days) and a follow-up visit which follows 30 days (+/- 14 days) after clinical resolution of underlying condition or after the end of the 14-day study period. Treatment can be continued after the 14-day study period if needed but such treatment isn't part of this Study. The Bleeding Record has to be filled in whenever any bleeding occurs during the Study.
Link
https://clinicaltrials.gov/ct2/show/NCT00039858
Keywords
Versions (1)
- 10/20/20 10/20/20 -
Copyright Holder
GlaxoSmithKline
Uploaded on
October 20, 2020
DOI
To request one please log in.
License
Creative Commons BY-NC 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Safety and Efficacy of Argatroban in Pediatric Patients, NCT00039858
Bleeding Record
- StudyEvent: ODM
Description
Did the patient experience any bleeding?
Alias
- UMLS CUI-1
- C0019080
- UMLS CUI-2
- C0347984
- UMLS CUI-3
- C0008976
Description
Bleeding Record
Alias
- UMLS CUI-1
- C0019080
Description
Bleeding site
Data type
integer
Alias
- UMLS CUI [1]
- C3258161
Description
Comment - bleeding
Data type
text
Alias
- UMLS CUI [1,1]
- C0947611
- UMLS CUI [1,2]
- C0019080
Description
(dd-mmm-yyyy)
Data type
date
Alias
- UMLS CUI [1,1]
- C0019080
- UMLS CUI [1,2]
- C0574845
Description
(0000-2359)
Data type
time
Alias
- UMLS CUI [1,1]
- C0019080
- UMLS CUI [1,2]
- C1301880
Description
(dd-mmm-yyyy)
Data type
date
Alias
- UMLS CUI [1,1]
- C0019080
- UMLS CUI [1,2]
- C0806020
Description
(0000-2359)
Data type
text
Alias
- UMLS CUI [1,1]
- C0019080
- UMLS CUI [1,2]
- C1522314
Description
Per protocol:
Data type
integer
Alias
- UMLS CUI [1,1]
- C0019080
- UMLS CUI [1,2]
- C0439793
Description
(List all Applicable)
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1547656
- UMLS CUI [1,2]
- C0019080
- UMLS CUI [1,3]
- C0549184
Description
(List all Applicable)
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1547656
- UMLS CUI [1,2]
- C0019080
- UMLS CUI [2]
- C0728907
Description
(List all Applicable)
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1547656
- UMLS CUI [1,2]
- C0019080
- UMLS CUI [2,1]
- C0457454
- UMLS CUI [2,2]
- C0304229
Description
(List all Applicable) Record on Transfusion Record Form.
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1547656
- UMLS CUI [1,2]
- C0019080
- UMLS CUI [2]
- C1879316
Description
(List all Applicable)
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1547656
- UMLS CUI [1,2]
- C0019080
- UMLS CUI [2,1]
- C0850891
- UMLS CUI [2,2]
- C0304229
Description
(List all Applicable)
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1547656
- UMLS CUI [1,2]
- C0019080
- UMLS CUI [1,3]
- C0205394
Description
Relation of bleeding to study drug
Data type
integer
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0869014
- UMLS CUI [1,3]
- C0019080
Description
If Yes: Serious event requires SAE page, AND must be reported via fax to GSK within 24 hours at CENSORED.
Data type
integer
Alias
- UMLS CUI [1,1]
- C0019080
- UMLS CUI [1,2]
- C0871902
Description
Major Bleeding Definition: Bleeding will be classified as major if one or more of the following pertain: • If it is overt and associated with a fall in the hemoglobin level of 2 grams/dL or more, • if it is retroperitoneal, • if it is intracranial.
Data type
integer
Alias
- UMLS CUI [1]
- C3160769
Similar models
Bleeding Record
- StudyEvent: ODM
C0019994 (UMLS CUI [1,2])
C2348184 (UMLS CUI [1,2])
C0347984 (UMLS CUI-2)
C0008976 (UMLS CUI-3)
C0347984 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0019080 (UMLS CUI [1,2])
C0574845 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C1522314 (UMLS CUI [1,2])
C0019080 (UMLS CUI [1,2])
C0549184 (UMLS CUI [1,3])
C0019080 (UMLS CUI [1,2])
C0728907 (UMLS CUI [2])
C0019080 (UMLS CUI [1,2])
C0457454 (UMLS CUI [2,1])
C0304229 (UMLS CUI [2,2])
C0019080 (UMLS CUI [1,2])
C1879316 (UMLS CUI [2])
C0019080 (UMLS CUI [1,2])
C0850891 (UMLS CUI [2,1])
C0304229 (UMLS CUI [2,2])
C0019080 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C0869014 (UMLS CUI [1,2])
C0019080 (UMLS CUI [1,3])
C0871902 (UMLS CUI [1,2])
No comments